 Provider News VirginiaDecember 30, 2022 January 2023 Anthem Provider News - VirginiaAdministrativeAdministrative | Anthem Blue Cross and Blue Shield | Commercial / Anthem Blue Cross and Blue Shield | Medicare Advantage | December 30, 2022 Engagement with your patient counts
As a reminder, we will update our claim editing software for professional services throughout 2023, with most updates occurring at a minimum quarterly. These updates apply to any provider, provider group (tax identification number) and/or across providers and claim type (professional/facility) and include, but are not limited to: - The addition of new, and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers) and associated edits such as:
- ICD-10 laterality
- Add-on procedures (indicated by + sign)
- Code book parenthetical statements and other directives about appropriate code use (for example, separate procedure, do not report, list separately in addition to, etc.)
- Updates to editing for multiple procedure reduction calculations based on relative value unit (RVU) as designated and updated by the Centers for Medicare & Medicaid (CMS) in the physician fee schedule relative value (PFSRV) files
- Updates to National Correct Coding Initiative edits (NCCI) and medically unlikely edits (MUEs)
- Updates to incidental, mutually exclusive, and unbundled (re-bundle) edits
- Updates to code edits associated with reimbursement policies including, but not limited to, updates to the edits that allow/disallow for assistant surgeon/co-surgeon/team surgeon, frequency edits, bundled services and global surgery preoperative and post-operative periods assigned by CMS
As a reminder, we will update our claim editing software for outpatient facility services throughout 2023 with most updates occurring at a minimum quarterly. These updates will include, but are not limited to: - The addition of new and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers, revenue codes) and associated edits.
- Updates related to the appropriate use of various code combinations, which can include, but are not limited to, CPT/HCPCS code to revenue code, type of bill to procedure code, type of bill to CPT/HCPCS code, and CPT/HCPCS code to modifier.
- Updates to National Correct Coding Initiative edits (NCCI) and Facility Outpatient Hospital Services Medically Unlikely Edits (MUEs).
- Updates to reflect coding requirements as designated by industry standard sources such as the National Uniform Billing Committee (NUBC) and the Centers for Medicare & Medicaid Services (CMS).
Beginning with dates of service on or after April 1, 2023, or the end of the public health emergency (PHE), whichever is later, reimbursement for COVID-19 laboratory service codes may be reduced for participating providers contracted with Anthem. New COVID-19 laboratory service codes were implemented and reimbursed at rates to meet the needs of providers during the PHE. Reimbursement will now be revised to Anthem's standard reimbursement methodology for the following codes: U0001 | 86328 | 87426 | 87811 | 0226U | U0002 | 86408 | 87428 | 0202U | 0240U | U0003 | 86409 | 87635 | 0223U | 0241U | U0004 | 86413 | 87636 | 0224U | | U0005 | 86769 | 87637 | 0225U | |
If you have any questions regarding this notice, please contact Provider Services or use Availity* Live Chat, which is available during normal business hours. Go to www.availity.com and select Anthem from the payer spaces drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat. * Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CRCM-013072-22 HEDIS® measurement year 2023 documentation for Childhood Immunization Status (CIS) Measure description:The percentage of children who turn 2 years of age in the measurement year who had the following vaccines on or before their second birthday: - Four DTaP (diphtheria, tetanus, and acellular pertussis)
- Three IPV (polio)
- One MMR (measles, mumps, and rubella)
- Three HiB (haemophilus influenza type B)
- Three hep B (hepatitis B)
- One VZV (chicken pox)
- Four PCV (pneumococcal conjugate)
- One hep A (hepatitis A)
- Two or three RV (rotavirus)
- Two flu (influenza)
The measure calculates a rate for each vaccine and three combination rates. HEDIS measurement year 2023 documentation for Lead Screening in Children (LSC) Measuredescription: The percentage of children 2 years of age who had one or more capillary or venous lead blood test for lead poisoning by their second birthday. In provider medical records, we look for the following: - Immunization records from birth (Department of Health immunization records are acceptable).
- If available, newborn inpatient records documenting hepatitis B.
- For immunizations not recorded on the immunization record, provide progress notes for:
- Immunizations administered.
- Patient’s history of disease (chickenpox, hep A, hep B, measles, mumps, rubella).
- Lead testing results and date (capillary or venous) on or before the second birthday.
- Evidence of hospice services in 2023.
- Evidence patient expired in 2023.
Helpful hints: - Childhood immunizations and lead blood tests must be completed by child’s second birthday.
- Assess immunization needs at every clinical encounter and, when indicated, immunize.
- Ensure immunization records include all vaccines that were ever given including hospitals, health departments, and all former providers, including refusals and contraindications.
- FluMist (LAIV) vaccination (only approved for ages 2 to 49) may be used for the second vaccination; however, it must be given on the child’s second birthday to be compliant.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). MULTI-BCBS-CRCM-012261-22-CPN11878 Why is this important? Each year, a random sample of enrolled members receive a CAHPS* Survey or a Qualified Health Plan Enrollee Survey asking them to evaluate their experiences with healthcare. The surveys ask members to rate their experiences with: - Their health plan.
- Their personal provider.
- Their specialist.
Several responses are combined and evaluated for the following: - Getting needed care
- Receiving care quickly
- Communicating with providers
- Sharing in the decision-making process
The responses give us an idea of how your patients and our members perceive us and provide opportunities for us to improve the way we deliver services. Our engagement and interaction with patients and members are critical. Together, we can provide positive experiences for our shared members and patients. Members receive the survey either by mail or phone between February and May. Some of the questions they are asked include: - In the last six1 months, how often did your personal provider explain things in a way that was easy to understand?
- In the last six1 months, how often did your personal provider listen carefully to you?
- In the last six1 months, how often did your personal provider show respect for what you had to say?
- In the last six1 months, how often did your personal provider spend enough time with you?
- Using any number from zero to 10, where zero is the worst personal provider possible, and 10 is the best personal provider possible, what number would you use to rate your personal doctor?
- We want to know your rating of the specialist you saw most often in the last six1 months. Using any number from zero to 10, where zero is the worst specialist possible and 10 is the best specialist possible, what number would you use to rate the specialist?
Every interaction with a patient is an opportunity to make their healthcare experience positive. We thank you for striving to provide quality care for our members and for the continued focus on improving our member experience. Additional information Continuing medical education (CME) education opportunities: http://www.mydiversepatients.com.
* CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). MULTI-BCBS-CRCM-008629-22-CPN6881 The following services will be added to precertification for the effective dates listed below. Precertification responsibility: The ordering or rendering provider of service is responsible for completing the precertification process. HMO plans: Services that require precertification will be denied if rendered without the appropriate precertification for in-network providers. HMO members may not have benefits for non-emergency services rendered outside of the network and are subject to review and may be denied. PPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. EPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. No out-of-network benefit is available with the exception of ER/urgent care and authorized services. Requesting precertification with the Virginia plan To obtain precertification, providers can access Availity* at www.availity.com or call the Utilization Management department using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved. Criteria | Criteria description | Codes | Effective date | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | 96365 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | 96372 | April 1, 2023 |
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. VABCBS-CM-012058-22 The following services will be added to precertification for the effective dates listed below. Precertification responsibility: The ordering or rendering provider of service is responsible for completing the precertification process. HMO plans: Services that require precertification will be denied if rendered without the appropriate precertification for in-network providers. HMO members may not have benefits for non-emergency services rendered outside of the network and are subject to review and may be denied. PPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. EPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. No out-of-network benefit is available with the exception of ER/urgent care and authorized services. Requesting precertification with the Virginia plan To obtain precertification, providers can access Availity* at www.availity.com or call the Utilization Management department using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved. Criteria | Criteria description | Codes | Effective date | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | 96365 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | 96372 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0456 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0696 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0698 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J2540 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | S9494 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | S9497 | April 1, 2023 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | S9504 | April 1, 2023 |
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. VABCBS-CM-012057-22 In November 2022, we shared information about updates to claim status inquiries denial descriptions. You should now see these expanded descriptions on your explanation of payment remittance advice. These simplified descriptions should make it easier to understand why your claim denied and how to update your claim with the information needed for processing. We’re phasing in clear, concise, and simplified denial descriptions that explain in greater detail why the claim or claim line has denied and what to do next. We’ve even included details about how to provide us with information digitally, to move the claim further along in the claims process. Continuing to improve The new denial descriptions will be phased in over the next few months. We’re starting with those claims or claim lines that have caused the most confusion based on your feedback. If new denial reasons are added, those descriptions will be expanded, as well. Save time. Increase efficiency. Go digital! If you’re not enrolled in Availity* Essentials, use this link for registration information: https://availity.com/Essentials-Portal-Registration. There is no cost for our providers to use the applications through Availity.com.
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CM-014766-22 The annual after-hours access studies performed by our vendor, North American Testing Organization* based in California, were resumed and fielded in the third quarter of 2022. This was to assess adequate phone messaging for our members with perceived emergency or urgent situations after regular office hours. Unfortunately, most of the Anthem Blue Cross and Blue Shield and our affiliate HealthKeepers, Inc. plans assessed fell short of the expectation of having a live person or a directive in place after hours. We will resume the survey in the second quarter of 2023 and expect when your office is contacted, you will be able to accommodate a member’s urgent concerns after hours. The main challenges the vendor has encountered while attempting to collect this required, essential data are related to an inability to reach the provider and/or the lack of after-hours messaging altogether. The challenges include: - Inaccurate provider information in the Anthem demographic database to allow assessment of the after-hours messaging.
- No voicemail or messaging at all.
- Voicemail not reflecting the practitioner’s name.
- Calls being automatically forwarded with no identification, no voicemail, or messaging.
To help your patients and Anthem reach your practice, we ask that you update your office information using the online Provider Maintenance Form and that you also review your after-hours messaging and connectivity for patients’ urgent accessibility. To be compliant, per the Provider Manual, have your messaging or answering service include appropriate instructions, such as: - Emergency situations:
- The compliant response for an emergency instructs the caller/patient to hang up and call 911 or go to the emergency room (ER) or connects the caller directly to the physician.
- Urgent situations:
- The compliant response for urgent needs would direct the caller to urgent care or ER, to call 911, or connect the caller to their physician or the physician on call.
Members must have access to care 24 hours a day, 7 days a week, 365 days a year. Primary care physicians (PCPs) must have arrangements for after-hours care to provide 24-hour coverage for members by a network provider during non-business office hours. Compliance requires that a recording or live person directs callers to urgent care, 911, the ER, or connects the call to the caller’s physician or physician on call. In addition to these measures, but not in place of them, the messaging can give callers the option of contacting their healthcare practitioner (via transfer, cell phone, pager, text, email, or voicemail) or an opportunity to ask for a call back for urgent questions or instructions. Is your practice compliant? * North American Testing Organization is an independent company providing survey service on behalf of Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. VABCBS-CM-014357-22 The following service will be added to the precertification list for the effective date listed below. Precertification responsibility: The ordering or rendering provider of service is responsible for completing the precertification process. HMO plans: Services that require precertification will be denied if rendered without the appropriate precertification for in-network providers. HMO members may not have benefits for non-emergency services rendered by out of network providers and are subject to review which could result in a denial. PPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. EPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. No out-of-network benefit is available with the exception of ER/Urgent Care and authorized services. Requesting precertification for Anthem Blue Cross and Blue Shield members in Virginia To obtain precertification, providers can access Availity Essentials* at Availity.com. To submit the authorization, select Authorizations from the home page. Calling the Utilization Management department using the number on the back of the member’s identification card can cause delays and digital submissions are recommended. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed. Criteria | Criteria description | Code | Effective date | MED.00057 | MRI Guided High Intensity Focused Ultrasound Ablation for Non-Oncologic Indications | 0398T | 4/1/2023 |
* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. VABCBS-CM-013080-22 Prior authorizations submitted digitally can reduce denials associated with manual submission errors. The Interactive Care Reviewer (ICR) prior authorization application makes it easy to submit, review, and check authorization status – all in one place. Learn how by attending our January 2023 ICR webcast. When: Tuesday, January 17, 2023 Noon Eastern time Register here Learn how to use ICR to: - Create an authorization request.
- Inquire on a previously submitted authorization.
- Update a case.
- Copy a case.
- View letters associated with a case.
- Request and check the status of an authorization appeal.
Visit the ICR target page to register, access self-service learning, and to view recorded learning sessions. Download ICR user guides and other job aides from the ICR target page too. You can also register from the Provider Learning Hub by selecting the ICR live webinar learning icon. Effective for dates of service on and after April 9, 2023, the following updates will apply to the AIM Specialty Health® (AIM)* Musculoskeletal — Interventional Pain Management Clinical Appropriateness Guidelines. As part of the AIM guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services. Interventional pain management — updates by section: - Epidural steroid injections:
- For nerve root compression due to herniated disc, specified that the MRI/CT showing this finding must have been done within 18 months instead of 12 months.
- Selective nerve root block:
- Included a second session for cases requiring evaluation of more than one level.
- Therapeutic intra-articular facet injections:
- Included criteria for repeat injections in patients who met criteria for an initial injection.
- Conservative management requirements:
- Aligned definitions with joint surgery, spine surgery, spine, and extremity imaging guidelines.
- More rigorous definition of the supervised home physical therapy requirement and removed cognitive behavioral therapy as a conservative care modality.
- Included activity modification and a trial of rest.
- Epidural steroid injections:
- Specified that only one spinal region may be treated per date of service.
- For repeat injection, prior injection must have provided improvement for three months instead of three weeks.
- Diagnostic medial branch block:
- Specified that up to four diagnostic sessions may be done in a rolling 12-month period (previously three).
- Reduced the number of unilateral levels that may be done in a session from three to two.
- Thermal medial branch radiofrequency neurotomy:
- Reduced the number of unilateral levels that may be done in a session from three to two.
- Specified a maximum of two radiofrequency sessions per rolling 12-month period.
- Regional sympathetic nerve block:
- Specified that procedure must be performed using imaging guidance.
- Specified that the procedure must be performed unilaterally.
- Specified a lifetime maximum of six blocks.
- Removed exclusions that referred to procedures which are no longer performed.
As a reminder, ordering and servicing providers may submit prior authorization requests to AIM:
- Through AIM’s ProviderPortalSM directly at providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines online. * AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CRCM-013444-22-CPN11940 Effective for dates of service on and after April 1, 2023, the following CPT® codes will be added to the AIM Specialty Health®* (AIM) Percutaneous Coronary Intervention Clinical Appropriateness Guidelines. Percutaneous Coronary Intervention: CPT code | Description | C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch | C9601 | Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) | C9602 | Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch | C9603 | Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) | C9604 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel | C9605 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure) | C9607 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel | C9608 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure) |
As a reminder, ordering and servicing providers may submit prior authorization requests to AIM through AIM’s ProviderPortalSM directly at www.providerportal.com. - Online access is available 24/7 to process orders in real time and is the fastest and most convenient way to request authorization.
If you have questions related to the guideline or code updates to the guideline noted above, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. * AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CM-012753-22 Effective for dates of service on and after April 9, 2023, the following updates will apply to the AIM Specialty Health®* (AIM) Radiation Oncology Clinical Appropriateness Guidelines. As part of the AIM guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services. - Radiation Therapy— Updates by section
- Gastrointestinal (GI) Cancers — Intensity modulated radiation therapy (IMRT)
- Removed plan comparison requirement for cholangiocarcinoma, esophageal, gastric, hepatocellular, and pancreatic cancer, because IMRT has become standard of care for curative treatment of these GI malignancies
- Oligometastatic Extracranial Disease— SBRT: stereotactic body radiation therapy (SBRT)
- Added indication for adrenal metastases as SABR-COMET trial listed this as one of the most common sites treated in that trial
- Prostate Cancer— Brachytherapy:
- Added indication for high-dose rate monotherapy in low- and intermediate-risk disease
- Image Guidance radiation therapy (IGRT)
- Added surface-based guidance technique (no change in intent or coding)
- Added statement that IGRT is not medically necessary to guide superficial radiotherapy for non-melanoma skin cancer (supported by American Society for Radiation Oncology [ASTRO] Clinical Practice Guideline)
As a reminder, ordering and servicing providers may submit prior authorization requests to AIM through the AIM ProviderPortalSM directly at www.providerportal.com. - Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
For questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you can access and download a copy of the current and upcoming guidelines here. * AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. VABCBS-CM-015782-22 Special note:The services addressed in ALL the Coverage Guidelines presented in this document will require authorization for all our products offered by HealthKeepers, Inc., with the exception of the Anthem HealthKeepers Plus, Medallion and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus). Other exceptions are Medicare Advantage and the Blue Cross and Blue Shield Service Benefit Plan (also called the Federal Employee Program® or FEP®). A pre-determination can be requested for our Anthem PPO products. Anthem Blue Cross and Blue Shield and our affiliate HealthKeepers, Inc. will implement the following new and revised Coverage Guidelines effective April 1, 2023. These guidelines impact all our products with the exception of Anthem HealthKeepers Plus, Medallion and Anthem CCC Plus offered by HealthKeepers, Inc.; Medicare Advantage; and the Blue Cross and Blue Shield Service Benefit Plan (also called the Federal Employee Program or FEP). These guidelines were among those recently approved at the Medical Policy and Technology Assessment Committee meeting held on November 10, 2022. The guidelines addressed in this edition of Provider News are: - Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling (GENE.00052).
- Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure Monitoring (MED.00130).
- Ingestible Devices for the Treatment of Constipation (MED.00143).
- Scoliosis Surgery (SURG.00097).
- Powered Wheeled Mobility Devices (CG-DME-31).
Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling (GENE.00052) This coverage guideline addresses several tests including: - Gene panel testing (For the purposes of this document, a gene panel is defined by five or more genes or gene variants tested on the same day on the same member by the same rendering provider.)
- Whole genome sequencing
- Whole exome sequencing
- Molecular profiling (also called comprehensive genomic profiling)
- Polygenic risk score testing
- Chromosome conformation signatures
The scope has been expanded to include chromosome confirmation signature testing. Chromosome confirmation signature testing is considered investigational and not medically necessary for all indications. The CPT® code associated with this revised coverage guideline and used to report chromosome confirmation signature testing is 0332U. Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure Monitoring (MED.00130) This coverage guideline addresses devices that use surface electromyography (sEMG) and electrodermal activity sensor devices to monitor seizures. The scope has been expanded to include electrodermal activity sensor devices. The use of surface electromyography (sEMG) or electrodermal activity sensor devices for seizure monitoring is considered investigational and not medically necessary. The HCPCS codes associated with this revised coverage guideline are E1399 and S3900. Ingestible Devices for the Treatment of Constipation (MED.00143) This new coverage guideline addresses the use of ingestible devices to mechanically stimulate the colon using vibration to treat constipation. Ingestible devices for the treatment of constipation are considered investigational and not medically necessary. The HCPCS code associated with this new coverage guideline is A9999. Scoliosis Surgery (SURG.00097) This coverage guideline addresses surgical treatments for scoliosis, specifically, use of a minimally invasive deformity correction system (for example, ApiFix, Ltd, Misgav Business Park, Israel), vertebral body tethering, vertebral body stapling, and magnetically controlled growing rods. The scope has been expanded to include magnetically controlled growing rods. Use of magnetically controlled growing rods for the treatment of scoliosis is considered investigational and not medically necessary. The CPT codes associated with this revised coverage guideline are 0656T, 0657T, and 22899. Powered Wheeled Mobility Devices (CG-DME-31) This Clinical UM Guideline addresses criteria for powered wheeled mobility devices (also referred to as power mobility devices). The scope has been revised to include powered wheeled mobility devices using computerized systems to assist with functions such as seat elevation and navigation over curbs, stairs, or uneven terrain (for example, the iBOT® Personal Mobility Device [iBOT PMD], Mobius Mobility, Manchester, NH). Powered wheeled mobility devices using computerized systems to assist with functions such as seat elevation and navigation over curbs, stairs, or uneven terrain (for example, the iBOT PMD) are considered not medically necessary for all indications The HCPCS codes associated with this revised clinical UM guideline are E1230; E1239; K0010; K0011; K0012; K0013; K0014, K0800; K0801; K0802; K0806; K0807; K0808; K0812, K0813; K0814; K0815; K0816, K0820; K0821; K0822; K0823; K0824; K0825; K0826; K0827; K0828; K0829; K0830; K0831; K0835; K0836; K0837; K0838; K0839; K0840; K0841; K0842; K0843, K0848; K0849; K0850; K0851; K0852; K0853; K0854; K0855; K0856; K0857; K0858; K0859; K0860; K0861; K0862; K0863; K0864, K0868; K0869; K0870; K0871; K0877; K0878; K0879; K0880; K0884; K0885; K0886, K0890; K0891, K0898; K0899, E1002; E1003; E1004; E1005; E1006; E1007; E1008; E1009; E1010; E1012; E2300, and E0986. These coverage guidelines are available for review on our website at anthem.com. Effective for dates of service on and after April 9, 2023, the following updates will apply to the AIM Specialty Health®* Cardiology Clinical Appropriateness Guidelines. As part of the AIM guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate and affordable healthcare services. Cardiac Imaging — Updates by section Stress testing with imaging: - Suspected coronary artery disease (CAD) without symptoms — Indications removed
- Suspected CAD with symptoms — Indications modified
- Need for testing determined by pretest probability
- Definition of chest pain expanded to include ischemic equivalent pain elsewhere
- Dyspnea included as standalone symptom
- Imaging modality to be selected by the treating physician
- Exercise preferred over pharmacologic testing in patients referred for stress testing with imaging
- Patients with atypical symptoms to undergo non-imaging stress testing (assuming capable of exercise and no precluding resting EKG abnormalities)
- Established CAD without symptoms — Indications removed
- Established CAD with symptoms — Indications removed
CT coronary angiography (CCTA): - Indications added — Considerable expansion in use for evaluation of CAD (now a first-line modality)
- Indications added — Preoperative testing indications
- Indications added — Abnormal prior testing indications
- Indications removed — Suspected anomalous coronary arteries (basis for suspicion required)
Fractional Flow Reserve from CCTA (FFR-CT): - Indication modified — 40% to 90% coronary stenosis in symptomatic patient who has failed guideline-directed medical therapy and has undergone CCTA within preceding 90 days
Stress Cardiac MRI: - Indications added — Considerable expansion in use for evaluation of CAD (now a first-line modality)
- Indications added — Preoperative testing indications
- Indications added — Abnormal prior testing indications
Resting Cardiac MRI: - Indication added — Fabry disease
- Indications modified — Suspected myocarditis (basis for suspicion required)
- Indications modified — Arrhythmogenic right ventricular dysplasia (ARVD) requirements clarified
- Indications modified — Suspected anomalous coronary arteries (basis for suspicion required)
Resting transthoracic echocardiography (TTE): - Valvular heart disease — updated frequency of surveillance in patients with prosthetic valves and those who had transcatheter valve replacement/repair; removed requirement of valvular dysfunction for those who had surgical mitral valve repair; removed moderate/severe mitral regurgitation for those who had transcatheter mitral valve repair
Diagnostic Coronary Angiography: - Indications modified — Clarification that patients with established CAD who have failed GDMT may undergo coronary angiography regardless of how initial diagnosis was made
As a reminder, ordering and servicing providers may submit prior authorization requests to AIM by accessing AIM’s ProviderPortalSM directly at www.providerportal.com: - Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. * AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CM-012489-22-CPN11939 Anthem Blue Cross and Blue Shield and our affiliate HealthKeepers, Inc. are committed to ongoing transparency in our relationship with our participating professional healthcare providers. Our reimbursement policies are intended to promote a better understanding of the reimbursement rules and claims editing logic that may impact payment for specific services covered under members’ benefit plans. Beginning with our upcoming amendment effective date of March 1, 2023*, the Commercial reimbursement policies will now be posted online at anthem.com. If you have questions about the coming changes, please contact your Anthem network manager. The provider manual has been historically posted on anthem.com and will continue to be provided online. However, the provider manual will not be included in contract packages after the upcoming amendment. Effective with dates of service on or after April 1, 2023, the Federal Employee Program® (FEP) with Anthem Blue Cross and Blue Shield (Anthem) will refer the following procedures for observation stay instead of full inpatient admission. These services will require prior authorization to determine medical necessity prior to rendering the service for Anthem federal employee members. For services that are scheduled to begin on or after April 1, 2023, all providers must be aware that for the following procedures, FEP will be approving observation stay versus inpatient stay when medically appropriate: - Knee arthroplasty (total/partial/revision knee)
- Shoulder arthroplasty (hemi arthroplasty/arthroscopy)
- Hip arthroplasty (total/partial/revision hip replacement) and hip arthroscopy
- Cervical fusion (anterior)
- Cervical discectomy or microdiscectomy, foraminotomy, and laminotomy
- Lumbar discectomy, foraminotomy, and/or laminotomy
- Small joint surgeries of the foot and ankle
- Reconstruction midface, LeFort I-III
- Sacral-Iliac fusion
How to submit a request for review Starting March 13, 2023, providers can begin submitting requests for review with dates of service on or after April 1, 2023. To reach the FEP Utilization Management (UM) department to submit an authorization request, providers may call our department directly, fax a request, or submit a request via Availity Essentials* with clinical information: - Phone number:800-860-2156
- Fax:800-732-8318
- Chat: To chat with an FEP UM representative, go to: availity.com. Select Payer Spaces, select Federal Employee Plan, and access the chat through Chat with Payer.
We value your participation in our network, as well as the services you provide. We look forward to working with you to help improve the health of our members. * Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield. MULTI-BCBS-CM-014832-22 The Medical Specialty Drug Review team for Anthem Blue Cross and Blue Shield manages prior authorization clinical review of non-oncology use of specialty pharmacy drugs. AIM Specialty Health®* (AIM), a separate company, manages review of specialty pharmacy drugs for oncology. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Including the national drug code (NDC) code on your claim may help expedite claim processing of drugs billed with a not otherwise classified (NOC) code. Clinical Criteria update: Effective January 1, 2023, clinical criteria naming will be changed from ING-CC-XXXX to CC-XXXX; however, the content within the documents will remain unchanged. Prior authorization updates Correction: In the August 2022 edition of Provider News, we published prior authorization updates for the drug Pluvicto (lutetium lu 177 vipivotide tetraxetan). Please be advised that the effective date for this update has been changed: - Previous effective date: November 1, 2022
- Updated effective date: February 1, 2023
Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0118* | Pluvicto (lutetium lu 177 vipivotide tetraxetan) | A9607 |
* Oncology use is managed by AIM. * AIM Specialty Health is an independent company providing some utilization review services on behalf of Anthem Blue Cross and Blue Shield. VABCBS-CM-014745-22 State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Engagement with your patient countsWhy is this important? Each year, a random sample of enrolled members receive a CAHPS* Survey or a Qualified Health Plan Enrollee Survey asking them to evaluate their experiences with healthcare. The surveys ask members to rate their experiences with: - Their health plan.
- Their personal provider.
- Their specialist.
Several responses are combined and evaluated for the following: - Getting needed care
- Receiving care quickly
- Communicating with providers
- Sharing in the decision-making process
The responses give us an idea of how your patients and our members perceive us and provide opportunities for us to improve the way we deliver services. Our engagement and interaction with patients and members are critical. Together, we can provide positive experiences for our shared members and patients. Members receive the survey either by mail or phone between February and May. Some of the questions they are asked include: - In the last six1 months, how often did your personal provider explain things in a way that was easy to understand?
- In the last six1 months, how often did your personal provider listen carefully to you?
- In the last six1 months, how often did your personal provider show respect for what you had to say?
- In the last six1 months, how often did your personal provider spend enough time with you?
- Using any number from zero to 10, where zero is the worst personal provider possible, and 10 is the best personal provider possible, what number would you use to rate your personal doctor?
- We want to know your rating of the specialist you saw most often in the last six1 months. Using any number from zero to 10, where zero is the worst specialist possible and 10 is the best specialist possible, what number would you use to rate the specialist?
Every interaction with a patient is an opportunity to make their healthcare experience positive. We thank you for striving to provide quality care for our members and for the continued focus on improving our member experience. Additional information Continuing medical education (CME) education opportunities: http://www.mydiversepatients.com. If you have any questions about this communication, call Anthem HealthKeepers Plus, Medallion Provider Services at 800‑901‑0020 or Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) Provider Services at 855‑323‑4687.
*CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). VABCBS-CD-008627-22-CPN6881 State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Childhood Immunization Status and Lead Screening in Children for HEDISHEDIS® measurement year 2023 documentation for Childhood Immunization Status (CIS) Measure description: The percentage of children who turn 2 years of age in the measurement year who had the following vaccines on or before their second birthday: - Four DTaP (diphtheria, tetanus, and acellular pertussis)
- Three IPV (polio)
- One MMR (measles, mumps, and rubella)
- Three HiB (haemophilus influenza type B)
- Three hep B (hepatitis B)
- One VZV (chicken pox)
- Four PCV (pneumococcal conjugate)
- One hep A (hepatitis A)
- Two or three RV (rotavirus)
- Two flu (influenza)
The measure calculates a rate for each vaccine and three combination rates. HEDIS measurement year 2023 documentation for Lead Screening in Children (LSC) Measure description: The percentage of children 2 years of age who had one or more capillary or venous lead blood test for lead poisoning by their second birthday. In provider medical records, we look for the following: - Immunization records from birth (Department of Health immunization records are acceptable).
- If available, newborn inpatient records documenting hepatitis B.
- For immunizations not recorded on the immunization record, provide progress notes for:
- Immunizations administered.
- Patient’s history of disease (chickenpox, hep A, hep B, measles, mumps, rubella).
- Lead testing results and date (capillary or venous) on or before the second birthday.
- Evidence of hospice services in 2023.
- Evidence patient expired in 2023.
Helpful hints: - Childhood immunizations and lead blood tests must be completed by child’s second birthday.
- Assess immunization needs at every clinical encounter and, when indicated, immunize.
- Ensure immunization records include all vaccines that were ever given including hospitals, health departments, and all former providers, including refusals and contraindications.
- FluMist (LAIV) vaccination (only approved for ages 2 to 49) may be used for the second vaccination; however, it must be given on the child’s second birthday to be compliant.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). VABCBS-CD-012259-22-CPN11878 State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Monkeypox and smallpox vaccines: Product code on claimsBackground Providers are a trusted resource for patients when it comes to vaccine advice. As information on the monkeypox outbreak changes and vaccination and testing guidance is released, we’re committed to keeping you informed. Some providers may have seen a message on their provider Explanation of Payment (EOP) stating that HealthKeepers, Inc. does not recognize the vaccine product codes for monkeypox and smallpox that became effective July 26, 2022. We’re updating the provider fee schedules to reflect the new vaccine product codes as quickly as possible. The EOP message did not impact payment for administration of the vaccines, which is reimbursable; however, since the monkeypox and smallpox vaccines are provided by the government at no charge, the vaccine products are non-reimbursable. To aid in processing claims for the monkeypox and smallpox vaccine products, providers must include these three elements on claims, even if vaccine products were received from the federal government at no charge: - Product code (90611 or 90622)
- Applicable ICD-10-CM diagnosis code
- Administration code
More detail on codes and cost-sharing Providers are encouraged to use: - Product code 90611 for smallpox and monkeypox vaccine.
- Product code 90622 for vaccinia (smallpox) virus vaccine.
- Code 87593 for laboratory testing.
When billing the monkeypox and smallpox vaccine products, providers should submit those codes with a $0.01 charge. If you have any questions about this communication, call Anthem HealthKeepers Plus, Medallion Provider Services at 800‑901‑0020 or Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) Provider Services at 855‑323‑4687. You can read more information on monkeypox online. VABCBS-CD-009131-22-CPN8697 State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Attention physicians and lab providers: COVID-19 update regarding reimbursementNotification regarding reimbursement changes to COVID-19 laboratory services codes Beginning with dates of service on or after January 12, 2023, or the end of the public health emergency (PHE), whichever is the latter, reimbursement for COVID-19 laboratory services codes will be reduced for providers contracted as independent laboratory (ancillary) providers and participating in an Anthem HealthKeepers Plus independent laboratory provider network. New COVID-19 laboratory service codes were implemented and reimbursed at rates to meet the needs of providers during the PHE. HealthKeepers, Inc. will revise reimbursement to standard reimbursement methodology for independent laboratory providers for the following codes: U0001 | 86328 | 87426 | 87811 | 0226U | U0002 | 86408 | 87428 | 0202U | 0240U | U0003 | 86409 | 87635 | 0223U | 0241U | U0004 | 86413 | 87636 | 0224U | | U0005 | 86769 | 87637 | 0225U | |
The revised standard fee schedule for the COVID-19 laboratory services codes outlined above can be viewed on www.Availity.com* beginning January 12, 2023. If you have any questions regarding this notice, please contact your designated Provider Network Manager. Please incorporate this notice into your Anthem HealthKeepers Plus provider agreement folder. If you have any questions about this communication, call Anthem HealthKeepers Plus, Medallion Provider Services at 800‑901‑0020 or Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) Provider Services at 855‑323‑4687. * Availity, LLC is an independent company providing administrative support services on behalf of HealthKeepers, Inc. VABCBS-CD-013050-22-CPN12350 State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Submitting prior authorizations digitally through ICRPrior authorizations submitted digitally can reduce denials associated with manual submission errors. The interactive care reviewer (ICR) prior authorization application makes it easy to submit, review, and check authorization status – all in one place. Learn how by attending our January 2023 ICR webcast. Tuesday, January 17, 2023 Noon Eastern time
Register here Learn how to use ICR to: - Create an authorization request.
- Inquire on a previously submitted authorization.
Update a case. - Copy a case.
View letters associated with a case. - Request and check the status of an authorization appeal.
Visit the ICR target page to register and to access self-service learning and to view recorded learning sessions. Download ICR user guides and other job aides from theICR target page too. You can also register from the Provider Learning Hub by selecting the ICR live webinar learning icon.
VABCBS-CD-014689-22-CPN14594 State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Implementation of Cardinal CareThis is an important message for all providers contracted with the Anthem HealthKeepers Plus network. Virginia’s Department of Medical Assistance Services (DMAS) will implement Cardinal Care effective January 1, 2023, which combines the two managed care programs — Medallion 4.0 and Commonwealth Coordinated Care Plus (CCC Plus) — to create a single identity for all members receiving services through Medicaid. Medallion 4.0 serves children, pregnant individuals and adults. CCC Plus serves older adults, disabled children and adults, and individuals receiving long-term services and supports (LTSS). Cardinal Care will continue to offer members the same programs and services and will not reduce or change any existing coverage. While new Cardinal Care-branded ID cards will be issued during the first quarter of 2023, providers should continue to accept the member’s current ID card. We will be consolidating customer service phone numbers for Medallion 4.0 and CCC Plus into one customer service phone number to provide seamless service to both members and providers. Please note these Cardinal Care customer service phone numbers: Member Services | 800-901-0020 | Provider Services | 800-901-0020 | Pharmacy | 833-207-3120 | 24/7 NurseLine | 800-901-0020 | Authorization | 800-901-0200 | Mental Health Services | 800-901-0200 | Transportation Service | 877-892-3988 |
Providers will continue to follow the same processes that currently exist to submit claims, verify eligibility, and verify benefits. Providers do not need to take any action at this time. HealthKeepers, Inc. and DMAS will continue to provide updates as needed. If you have any questions about this communication, call Provider Services at 800‑901‑0020 or your Provider Experience representative. State & Federal | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | December 30, 2022 Keep up with Medicaid news: January 2023Please continue to check our website https://providers.anthem.com/virginia-provider/home for the latest Medicaid information for members enrolled in HealthKeepers, Inc.’s Anthem HealthKeepers Plus and the Commonwealth Coordinated Care Plus (Anthem CCC Plus) benefit plans. Here are the topics we’re addressing in this edition:
|